Keyphrases
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
74%
Hematopoietic Stem Cell Transplantation
67%
Graft-versus-host Disease (GvHD)
40%
Pediatric Hematopoietic Stem Cell Transplantation
39%
Pediatric
30%
Sinusoidal Obstruction Syndrome
26%
Systemic Inflammation
21%
Interleukin-7 (IL-7)
19%
Insulin-like
14%
Growth Factors
14%
Severe Acute
12%
T Cell Reconstitution
10%
Interleukin-7 Receptor
9%
Glucagon-like
9%
Cytomegalovirus Infection
9%
Chimeric Antigen Receptor T-cell Therapy
9%
Plasma Parameters
9%
T Cells
9%
Reconstitution
8%
Insulin-like Growth factor-1
8%
Antithymocyte Globulin
7%
Confidence Interval
7%
Binding Protein
7%
Interleukin-6
7%
Chimeric Antigen Receptor T Cells (CAR-T)
7%
Transplantation
7%
Risk Factors
6%
Citrulline
6%
Peripheral T Cells
6%
Non-infectious
6%
Engraftment Syndrome
6%
B Cells
6%
Treatment Complications
6%
T Helper 17 (Th17)
6%
Day 14
6%
Gastrointestinal Toxicity
6%
Rs6897932
6%
Donor Genotype
6%
Pediatric Patients
5%
Lymphocytes
5%
C-reactive Protein
5%
Lymphopenia
5%
Severity Grading
5%
Myeloablative
5%
Immunology and Microbiology
Hematopoietic Stem Cell Transplantation
100%
Allogeneic Hematopoietic Stem Cell Transplantation
74%
Acute Graft Versus Host Disease
37%
T Cell
25%
Systemic Inflammation
25%
Interleukin 7
24%
Conditioning
23%
Transplant Procedure
20%
Blood Plasma
19%
Graft-Versus-Host Disease
15%
Somatomedin C
14%
C-Reactive Protein
12%
Blood Level
12%
Chronic Graft Versus Host Disease
11%
Interleukin-6
10%
Cytomegalovirus Infection
9%
Interleukin-7 Receptor
9%
Somatomedin
8%
Anti-Thymocyte Globulin
7%
Protein Binding
7%
Regulatory T Cell
7%
Engraftment Syndrome
6%
Cytokine
6%
Neutrophil
5%
Lymphocytopenia
5%
Drug Megadose
5%
